FAP-a and GOLPH3 Are Hallmarks of DCIS Progression to Invasive Breast Cancer

Biological markers that could predict the progression of ductal carcinoma in-situ (DCIS) to invasive breast cancer (IDC) are required urgently for personalized therapy for patients diagnosed with DCIS. As stroma was invaded by malignant cells, perturbed stromal-epithelial interactions would bring ab...

Full description

Bibliographic Details
Main Authors: Li-Na Yu, Zhen Liu, Yan Tian, Pei-Pei Zhao, Xing Hua
Format: Article
Language:English
Published: Frontiers Media S.A. 2019-12-01
Series:Frontiers in Oncology
Subjects:
Online Access:https://www.frontiersin.org/article/10.3389/fonc.2019.01424/full
_version_ 1819265559803461632
author Li-Na Yu
Li-Na Yu
Li-Na Yu
Zhen Liu
Yan Tian
Yan Tian
Yan Tian
Pei-Pei Zhao
Pei-Pei Zhao
Pei-Pei Zhao
Xing Hua
author_facet Li-Na Yu
Li-Na Yu
Li-Na Yu
Zhen Liu
Yan Tian
Yan Tian
Yan Tian
Pei-Pei Zhao
Pei-Pei Zhao
Pei-Pei Zhao
Xing Hua
author_sort Li-Na Yu
collection DOAJ
description Biological markers that could predict the progression of ductal carcinoma in-situ (DCIS) to invasive breast cancer (IDC) are required urgently for personalized therapy for patients diagnosed with DCIS. As stroma was invaded by malignant cells, perturbed stromal-epithelial interactions would bring about tissue remodeling. With the specific expression of the fibroblast activation protein-alpha (FAP-a), Carcinoma-associated fibroblasts (CAFs) are the main cell populations in the remodeled tumor stroma. Golgi phosphoprotein 3 (GOLPH3), a documented oncogene possessing potent transforming capacity, is not only up-regulated in many tumors but also an efficient indicator of poor prognosis and more malignant tumors. The present study aimed to retrospectively evaluate the pathological value of FAP-a and GOLPH3 in predicting the recurrence or progression of DCIS to invasive breast cancer. Immunohistochemical techniques were applied to investigate the expression of FAP-a GOLPH3 in 449 cases of DCIS patients received extensive resection and with close follow-up, but not being treated with any form of chemo- or radio-therapy. The combination of FAP-a and GOLPH3 in predicating the recurrence or progression of DCIS into invasive breast cancer was specifically examined. The study demonstrated that the overexpression of FAP-a in stromal fibroblasts and GOLPH3 in carcinoma cells are highly predictive of DCIS recurrence and progression into invasive breast cancer. Both FAP-a and GOLPH3 have high specificity and sensitivity to predict the recurrence of DCIS. Moreover, the combination of FAP-a and GOLPH3 tends to further improve the specificity and sensitivity of DCIS recurrence by 9.72–10.31 and 2.72–3.63%, respectively. FAP-a and GOLPH3 serve as novel markers in predicting the recurrence or progression of DCIS into invasive breast cancer.
first_indexed 2024-12-23T20:47:19Z
format Article
id doaj.art-2506343610cb4c56915a4af698ead5ae
institution Directory Open Access Journal
issn 2234-943X
language English
last_indexed 2024-12-23T20:47:19Z
publishDate 2019-12-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Oncology
spelling doaj.art-2506343610cb4c56915a4af698ead5ae2022-12-21T17:31:45ZengFrontiers Media S.A.Frontiers in Oncology2234-943X2019-12-01910.3389/fonc.2019.01424476308FAP-a and GOLPH3 Are Hallmarks of DCIS Progression to Invasive Breast CancerLi-Na Yu0Li-Na Yu1Li-Na Yu2Zhen Liu3Yan Tian4Yan Tian5Yan Tian6Pei-Pei Zhao7Pei-Pei Zhao8Pei-Pei Zhao9Xing Hua10Department of Pathology, Nanfang Hospital, Guangzhou, ChinaDepartment of Pathology, School of Basic Medical Sciences, Southern Medical University, Guangzhou, ChinaGuangdong Provincial Key Laboratory of Molecular Tumor Pathology, Guangzhou, ChinaDepartment of Pathology, School of Clinical Medicine, Guizhou Medical University, Guiyang, ChinaDepartment of Pathology, Nanfang Hospital, Guangzhou, ChinaDepartment of Pathology, School of Basic Medical Sciences, Southern Medical University, Guangzhou, ChinaGuangdong Provincial Key Laboratory of Molecular Tumor Pathology, Guangzhou, ChinaDepartment of Pathology, Nanfang Hospital, Guangzhou, ChinaDepartment of Pathology, School of Basic Medical Sciences, Southern Medical University, Guangzhou, ChinaGuangdong Provincial Key Laboratory of Molecular Tumor Pathology, Guangzhou, ChinaDepartment of Pathology, Guangzhou Red Cross Hospital, Medical College, Jinan University, Guangzhou, ChinaBiological markers that could predict the progression of ductal carcinoma in-situ (DCIS) to invasive breast cancer (IDC) are required urgently for personalized therapy for patients diagnosed with DCIS. As stroma was invaded by malignant cells, perturbed stromal-epithelial interactions would bring about tissue remodeling. With the specific expression of the fibroblast activation protein-alpha (FAP-a), Carcinoma-associated fibroblasts (CAFs) are the main cell populations in the remodeled tumor stroma. Golgi phosphoprotein 3 (GOLPH3), a documented oncogene possessing potent transforming capacity, is not only up-regulated in many tumors but also an efficient indicator of poor prognosis and more malignant tumors. The present study aimed to retrospectively evaluate the pathological value of FAP-a and GOLPH3 in predicting the recurrence or progression of DCIS to invasive breast cancer. Immunohistochemical techniques were applied to investigate the expression of FAP-a GOLPH3 in 449 cases of DCIS patients received extensive resection and with close follow-up, but not being treated with any form of chemo- or radio-therapy. The combination of FAP-a and GOLPH3 in predicating the recurrence or progression of DCIS into invasive breast cancer was specifically examined. The study demonstrated that the overexpression of FAP-a in stromal fibroblasts and GOLPH3 in carcinoma cells are highly predictive of DCIS recurrence and progression into invasive breast cancer. Both FAP-a and GOLPH3 have high specificity and sensitivity to predict the recurrence of DCIS. Moreover, the combination of FAP-a and GOLPH3 tends to further improve the specificity and sensitivity of DCIS recurrence by 9.72–10.31 and 2.72–3.63%, respectively. FAP-a and GOLPH3 serve as novel markers in predicting the recurrence or progression of DCIS into invasive breast cancer.https://www.frontiersin.org/article/10.3389/fonc.2019.01424/fullFAP-aGOLPH3DCISrecurrencebreast cancer
spellingShingle Li-Na Yu
Li-Na Yu
Li-Na Yu
Zhen Liu
Yan Tian
Yan Tian
Yan Tian
Pei-Pei Zhao
Pei-Pei Zhao
Pei-Pei Zhao
Xing Hua
FAP-a and GOLPH3 Are Hallmarks of DCIS Progression to Invasive Breast Cancer
Frontiers in Oncology
FAP-a
GOLPH3
DCIS
recurrence
breast cancer
title FAP-a and GOLPH3 Are Hallmarks of DCIS Progression to Invasive Breast Cancer
title_full FAP-a and GOLPH3 Are Hallmarks of DCIS Progression to Invasive Breast Cancer
title_fullStr FAP-a and GOLPH3 Are Hallmarks of DCIS Progression to Invasive Breast Cancer
title_full_unstemmed FAP-a and GOLPH3 Are Hallmarks of DCIS Progression to Invasive Breast Cancer
title_short FAP-a and GOLPH3 Are Hallmarks of DCIS Progression to Invasive Breast Cancer
title_sort fap a and golph3 are hallmarks of dcis progression to invasive breast cancer
topic FAP-a
GOLPH3
DCIS
recurrence
breast cancer
url https://www.frontiersin.org/article/10.3389/fonc.2019.01424/full
work_keys_str_mv AT linayu fapaandgolph3arehallmarksofdcisprogressiontoinvasivebreastcancer
AT linayu fapaandgolph3arehallmarksofdcisprogressiontoinvasivebreastcancer
AT linayu fapaandgolph3arehallmarksofdcisprogressiontoinvasivebreastcancer
AT zhenliu fapaandgolph3arehallmarksofdcisprogressiontoinvasivebreastcancer
AT yantian fapaandgolph3arehallmarksofdcisprogressiontoinvasivebreastcancer
AT yantian fapaandgolph3arehallmarksofdcisprogressiontoinvasivebreastcancer
AT yantian fapaandgolph3arehallmarksofdcisprogressiontoinvasivebreastcancer
AT peipeizhao fapaandgolph3arehallmarksofdcisprogressiontoinvasivebreastcancer
AT peipeizhao fapaandgolph3arehallmarksofdcisprogressiontoinvasivebreastcancer
AT peipeizhao fapaandgolph3arehallmarksofdcisprogressiontoinvasivebreastcancer
AT xinghua fapaandgolph3arehallmarksofdcisprogressiontoinvasivebreastcancer